Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Skeletal | 11 | 2025 | 82 | 5.050 |
Why?
|
| Signal Transduction | 9 | 2025 | 225 | 2.310 |
Why?
|
| Regeneration | 4 | 2025 | 15 | 1.990 |
Why?
|
| Muscle Development | 3 | 2024 | 13 | 1.920 |
Why?
|
| Endoribonucleases | 3 | 2024 | 9 | 1.910 |
Why?
|
| Myoblasts | 2 | 2024 | 10 | 1.790 |
Why?
|
| X-Box Binding Protein 1 | 3 | 2024 | 7 | 1.740 |
Why?
|
| Muscular Diseases | 2 | 2024 | 5 | 1.710 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2025 | 6 | 1.680 |
Why?
|
| Mice | 16 | 2025 | 719 | 1.650 |
Why?
|
| MAP Kinase Kinase Kinases | 2 | 2023 | 4 | 1.620 |
Why?
|
| Muscular Atrophy | 5 | 2022 | 21 | 1.510 |
Why?
|
| Satellite Cells, Skeletal Muscle | 3 | 2025 | 6 | 1.400 |
Why?
|
| Cell Differentiation | 4 | 2025 | 75 | 1.390 |
Why?
|
| Animals | 18 | 2025 | 1817 | 1.350 |
Why?
|
| Mice, Inbred mdx | 2 | 2025 | 5 | 1.160 |
Why?
|
| Cell Communication | 2 | 2025 | 16 | 1.100 |
Why?
|
| TWEAK Receptor | 2 | 2023 | 5 | 1.090 |
Why?
|
| Peripheral Arterial Disease | 2 | 2023 | 4 | 1.030 |
Why?
|
| Cell Fusion | 1 | 2024 | 5 | 0.930 |
Why?
|
| Respiratory Insufficiency | 1 | 2024 | 2 | 0.910 |
Why?
|
| Mice, Knockout | 6 | 2024 | 143 | 0.880 |
Why?
|
| Tumor Necrosis Factors | 1 | 2022 | 2 | 0.830 |
Why?
|
| Exercise Tolerance | 1 | 2022 | 5 | 0.830 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2022 | 2 | 0.790 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2021 | 4 | 0.760 |
Why?
|
| NF-kappa B | 1 | 2021 | 11 | 0.750 |
Why?
|
| Muscle Proteins | 2 | 2024 | 11 | 0.460 |
Why?
|
| Myocytes, Cardiac | 2 | 2025 | 40 | 0.460 |
Why?
|
| Unfolded Protein Response | 3 | 2024 | 5 | 0.440 |
Why?
|
| Gene Expression Regulation | 2 | 2024 | 77 | 0.400 |
Why?
|
| Humans | 6 | 2024 | 5485 | 0.310 |
Why?
|
| Autophagy | 2 | 2021 | 31 | 0.300 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 242 | 0.300 |
Why?
|
| Heart Ventricles | 2 | 2025 | 25 | 0.290 |
Why?
|
| Cell Proliferation | 2 | 2025 | 120 | 0.280 |
Why?
|
| Oxidative Stress | 2 | 2024 | 59 | 0.270 |
Why?
|
| Ischemia | 2 | 2023 | 4 | 0.260 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2024 | 13 | 0.240 |
Why?
|
| Cell Self Renewal | 1 | 2025 | 1 | 0.240 |
Why?
|
| PAX7 Transcription Factor | 1 | 2025 | 1 | 0.240 |
Why?
|
| Endocardium | 1 | 2025 | 6 | 0.240 |
Why?
|
| STAT3 Transcription Factor | 1 | 2025 | 5 | 0.240 |
Why?
|
| Th17 Cells | 1 | 2024 | 1 | 0.230 |
Why?
|
| Myocardium | 1 | 2025 | 35 | 0.230 |
Why?
|
| Integrin beta1 | 1 | 2024 | 10 | 0.230 |
Why?
|
| Fibronectins | 1 | 2024 | 13 | 0.230 |
Why?
|
| Extracellular Matrix | 1 | 2024 | 14 | 0.230 |
Why?
|
| Heart | 1 | 2025 | 46 | 0.230 |
Why?
|
| Neutrophils | 1 | 2024 | 19 | 0.230 |
Why?
|
| Asthma | 1 | 2024 | 11 | 0.230 |
Why?
|
| Selenoproteins | 1 | 2024 | 2 | 0.230 |
Why?
|
| Biomarkers | 2 | 2021 | 87 | 0.220 |
Why?
|
| Apoptosis | 1 | 2024 | 55 | 0.220 |
Why?
|
| Polymyxin B | 1 | 2024 | 28 | 0.220 |
Why?
|
| Wnt Signaling Pathway | 1 | 2023 | 8 | 0.220 |
Why?
|
| Succinate Dehydrogenase | 1 | 2023 | 1 | 0.220 |
Why?
|
| Membrane Proteins | 1 | 2024 | 49 | 0.220 |
Why?
|
| Hypertrophy | 1 | 2023 | 5 | 0.210 |
Why?
|
| Marfan Syndrome | 1 | 2022 | 1 | 0.210 |
Why?
|
| Mitochondria | 1 | 2023 | 23 | 0.210 |
Why?
|
| Cell Respiration | 1 | 2022 | 2 | 0.200 |
Why?
|
| Phosphorylation | 1 | 2022 | 50 | 0.200 |
Why?
|
| Toll-Like Receptors | 1 | 2021 | 4 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 183 | 0.190 |
Why?
|
| MicroRNAs | 1 | 2021 | 55 | 0.180 |
Why?
|
| Muscles | 1 | 2020 | 6 | 0.180 |
Why?
|
| Biological Assay | 2 | 2021 | 33 | 0.170 |
Why?
|
| Male | 1 | 2025 | 2770 | 0.130 |
Why?
|
| Morphogenesis | 2 | 2025 | 28 | 0.120 |
Why?
|
| Estrogens | 2 | 2023 | 21 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 195 | 0.100 |
Why?
|
| Organogenesis | 1 | 2025 | 10 | 0.060 |
Why?
|
| Nanotubes | 1 | 2025 | 9 | 0.060 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2024 | 9 | 0.060 |
Why?
|
| Cell Shape | 1 | 2024 | 10 | 0.060 |
Why?
|
| Interleukin-23 | 1 | 2024 | 1 | 0.060 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2024 | 3 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2024 | 41 | 0.060 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-2 | 1 | 2024 | 7 | 0.060 |
Why?
|
| Lung | 1 | 2024 | 42 | 0.060 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2024 | 27 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2024 | 15 | 0.060 |
Why?
|
| Cell Movement | 1 | 2024 | 64 | 0.060 |
Why?
|
| Cell Survival | 1 | 2024 | 57 | 0.060 |
Why?
|
| Cell Line | 1 | 2024 | 86 | 0.060 |
Why?
|
| Hindlimb | 1 | 2023 | 4 | 0.050 |
Why?
|
| Genetic Therapy | 1 | 2023 | 8 | 0.050 |
Why?
|
| Affinity Labels | 1 | 2003 | 2 | 0.050 |
Why?
|
| Plasmids | 1 | 2003 | 20 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 1 | 2023 | 17 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 50 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2023 | 24 | 0.050 |
Why?
|
| RNA | 1 | 2003 | 30 | 0.050 |
Why?
|
| Copper | 1 | 2003 | 34 | 0.050 |
Why?
|
| Fibrosis | 1 | 2022 | 14 | 0.050 |
Why?
|
| Peptide Initiation Factors | 1 | 2021 | 4 | 0.050 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2021 | 8 | 0.050 |
Why?
|
| Autophagosomes | 1 | 2021 | 3 | 0.050 |
Why?
|
| Autophagy-Related Proteins | 1 | 2021 | 4 | 0.050 |
Why?
|
| Lysosomes | 1 | 2021 | 21 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2016 | 187 | 0.030 |
Why?
|
| Acrylamides | 1 | 2003 | 3 | 0.010 |
Why?
|
| Chemical Precipitation | 1 | 2003 | 8 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 8 | 0.010 |
Why?
|
| Imidazoles | 1 | 2003 | 15 | 0.010 |
Why?
|
| Chelating Agents | 1 | 2003 | 11 | 0.010 |
Why?
|
| Metals | 1 | 2003 | 17 | 0.010 |
Why?
|
| DNA | 1 | 2003 | 65 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2003 | 111 | 0.010 |
Why?
|